Target intelligence / Profile preview

Mycobacterium tuberculosis oxidative phosphorylation system (Mtb OXPHOS)

Target
Mtb OXPHOS
Molecular classification
Enzyme, Ion channel, Transporter, Protein complex
01

Overview

The Mycobacterium tuberculosis oxidative phosphorylation system, often referred to as membrane energetics, is a critical metabolic pathway responsible for generating adenosine triphosphate (ATP) required for bacterial survival, growth, and persistence. Unlike many other bacteria, M. tuberculosis is an obligate aerobe that relies heavily on its respiratory chain to maintain a proton motive force across the plasma membrane, even during periods of dormancy or low metabolic activity. This system comprises several key components, including NADH dehydrogenases, the menaquinone pool, the cytochrome bc1-aa3 oxidase complex, and the F1F0-ATP synthase. Targeting membrane energetics has emerged as a highly effective strategy for treating both drug-sensitive and multi-drug-resistant tuberculosis (MDR-TB). Drugs like bedaquiline specifically bind to the c-subunit of ATP synthase, effectively 'starving' the bacteria of energy, while newer candidates like telacebec target the QcrB subunit of the cytochrome complex. Because these bioenergetic processes are distinct from those in human mitochondria or are sufficiently divergent in structure, they offer a high degree of selectivity. This pathway is particularly vital for killing non-replicating persistent mycobacteria, which are often responsible for treatment relapse and require long-duration therapy.

Other names
Mycobacterium tuberculosis membrane energeticsMycobacterium tuberculosis respiratory chainMtb electron transport chainMtb bioenergetics pathway
02

Mechanism of action

Inhibition of ATP synthase (subunit c), inhibition of the cytochrome bc1-aa3 complex (QcrB), or disruption of the proton motive force across the mycobacterial inner membrane.

03

Biological functions

ATP synthesisElectron transportProton gradient maintenanceOxidative phosphorylationEnergy metabolism
04

Disease associations

Infection
05

Safety considerations

QT prolongation (specifically with Bedaquiline and Clofazimine)Hepatic toxicityDrug-drug interactions via CYP3A4Potential for mitochondrial cross-reactivity in host cells
06

Interacting drugs

Bedaquiline

4 more in the full profile.

07

Biomarkers

Sputum culture conversionMycobacterial load (CFU)Time to positivity (TTP) in liquid culture

Beyond the preview

Go deeper on Mycobacterium tuberculosis oxidative phosphorylation system (Mtb OXPHOS).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mycobacterium tuberculosis oxidative phosphorylation system (Mtb OXPHOS).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call